- Cat. No.
- A38021
(-)-TK216 (l-TK216)
(-)-TK216 is the enantiomer of TK216, a potent and orally bioavailable inhibitor of E26 transformation-specific (ETS) transcription factors. This compound exhibits significant anti-cancer activity, making it a valuable tool for research focused on gene regulation and oncogenic pathways. Its efficacy in targeting ETS-related mechanisms positions (-)-TK216 as a pertinent compound for investigative studies in cancer biology and therapeutic development.